Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA, Genesis Genome Ink Distribution Agreement for Malaysia

NEW YORK (GenomeWeb) – OncoDNA today announced a distribution deal with Malaysian oncology firm Genesis Genome to bring affordable theranostic analysis to that country. 

Under the terms of the deal, Genesis Genome has selected OncoDNA as its exclusive supplier of clinical grade molecular theranostics and will make available to Malaysian physicians OncoDNA's OncoDeep DX and OncoDeep Clinical cancer panels combined with its Package Plus, enabling clinically relevant interpretations of patients' tumors using the OncoShare web platform. 

OncoDeep DX comprises 65 genes while the OncoDeep Clinical cancer panel comprises 409 genes. Package Plus is made up of immunohistochemistry and other tests to analyze the presence of key proteins and activity and translocations. 

Financial and other terms of the deal were not disclosed. 

The agreement is the 16th reached by OncoDNA, it said. In recent months, the Belgium firm inked similar deals with the Eone-Diagnomics Genome Center, Progenetics, and BioSequence

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.